Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03568162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of ISB 830 in Adult Subjects With Moderate to Severe Atopic Dermatitis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2b, randomized, double-blinded, placebo-controlled dose range finding study to evaluate the efficacy, safety and tolerability of ISB 830 in adults with moderate to severe atopic dermatitis. The study will be conducted in 2 Parts, with dosing Groups 1-4 comprising Part 1, and dosing Groups 5-6 comprising Part 2. All subjects will receive open-label ISB 830 after a 16 week blinded treatment period.
Study identification
- NCT ID
- NCT03568162
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 462 participants
Conditions and interventions
Conditions
Interventions
- ISB 830 - Part 1 Group 1 Drug
- ISB 830 - Part 1 Group 2 Drug
- ISB 830 - Part 1 Group 3 Drug
- Placebo - Part 1 Group 4 Drug
- ISB 830 - Part 2 Group 5 Drug
- Placebo - Part 2 Group 6 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 30, 2018
- Primary completion
- Aug 10, 2020
- Completion
- Aug 2, 2021
- Last update posted
- Aug 22, 2022
2018 – 2021
United States locations
- U.S. sites
- 34
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ichnos Investigational Site 129 | Birmingham | Alabama | 35209 | — |
| Ichnos Investigational Site 120 | Clovis | California | 93711 | — |
| Ichnos Investigational Site 105 | Rolling Hills Estates | California | 90274 | — |
| Ichnos Investigational Site 106 | Bridgeport | Connecticut | 06606 | — |
| Ichnos Investigational Site 146 | Danbury | Connecticut | 06810 | — |
| Ichnos Investigational Site 142 | Brandon | Florida | 33511 | — |
| Ichnos Investigational Site 143 | Fort Myers | Florida | 33912 | — |
| Ichnos Investigational Site 148 | Lake City | Florida | 32055 | — |
| Ichnos Investigational Site 141 | Lake Worth | Florida | 33461 | — |
| Ichnos Investigational Site 140 | Miami | Florida | 33156 | — |
| Ichnos Investigational Site 123 | Miami | Florida | 33175 | — |
| Ichnos Investigational Site 147 | Ormond Beach | Florida | 32174 | — |
| Ichnos Investigational site 101 | Tampa | Florida | 33607 | — |
| Ichnos Investigational Site 135 | Tampa | Florida | 33612 | — |
| Ichnos Investigational Site 115 | Newnan | Georgia | 30263 | — |
| Ichnos Investigational Site 139 | Savannah | Georgia | 31406 | — |
| Ichnos Investigational Site 112 | Plainfield | Indiana | 46168 | — |
| Ichnos Investigational Site 125 | West Des Moines | Iowa | 50265 | — |
| Ichnos Investigational Site109 | New Orleans | Louisiana | 70115 | — |
| Ichnos Investigational Site 126 | St Louis | Missouri | 63141 | — |
| Ichnos Investigational Site 144 | Las Vegas | Nevada | 89120 | — |
| Ichnos Investigational Site 117 | Verona | New Jersey | 07044-2946 | — |
| Glenmark Investigational Site 102 | Forest Hills | New York | 11375 | — |
| Ichnos Investigational Site 114 | Medford | Oregon | 97504-9741 | — |
| Ichnos Investigational Site 133 | Hazleton | Pennsylvania | 18201 | — |
| Ichnos Investigational Site 122 | Philadelphia | Pennsylvania | 19103 | — |
| Ichnos Investigational Site 132 | Chattanooga | Tennessee | 37421 | — |
| Ichnos Investigational Site 119 | Houston | Texas | 77004 | — |
| Ichnos Investigational Site 138 | Pflugerville | Texas | 78660 | — |
| Ichnos Investigational Site 116 | San Antonio | Texas | 78258 | — |
| Ichnos Investigational Site 110 | Waco | Texas | 76710 | — |
| Ichnos Investigational Site 103 | Newport News | Virginia | 23606-4537 | — |
| Ichnos Investigational Site 131 | Richmond | Virginia | 23220 | — |
| Ichnos Investigational Site 136 | Spokane | Washington | 99224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03568162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2022 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03568162 live on ClinicalTrials.gov.